PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för pirfenidone. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

13 hits

Bibliografisk träff 2015-03-03

Pirfenidone inhibits proliferation, arrests the cell cycle, and downregulates heat shock protein-47 and collagen type I in rat hepatic stellate cells in vitro.

Xiang XH, Jiang TP, Zhang S, Song J, Li X, Yang JY, Zhou S.

Mol Med Rep · research support, non-u.s. gov't; journal article · DOI 10.3892/mmr.2015.3403

Bibliografisk träff 2015-03-01

Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis.

Cottin V, Maher T.

Eur Respir Rev · review-article; review; journal article · DOI 10.1183/09059180.00011514

Bibliografisk träff 2015-02-26

Do all patients with idiopathic pulmonary fibrosis warrant a trial of therapeutic intervention? A pro-con perspective.

Moodley Y, Corte T, Richeldi L, King TE.

Respirology · review; journal article · DOI 10.1111/resp.12484

Bibliografisk träff 2015-02-18

IPF Care: a support program for patients with idiopathic pulmonary fibrosis treated with pirfenidone in Europe.

Duck A, Pigram L, Errhalt P, Ahmed D, Chaudhuri N.

Adv Ther · research support, non-u.s. gov't; review-article; review; journal article · DOI 10.1007/s12325-015-0183-7

Bibliografisk träff 2015-02-11

Combination pirfenidone and inhaled N-acetylcysteine therapy for IPF: does it take these two to tango?

Velez MI, Nambiar AM.

Respirology · comment; editorial · DOI 10.1111/resp.12487

Bibliografisk träff 2015-02-02

Effectiveness of combined therapy with pirfenidone and inhaled N-acetylcysteine for advanced idiopathic pulmonary fibrosis: a case-control study.

Sakamoto S, Muramatsu Y, Satoh K, Ishida F, Kikuchi N, Sano G, Sugino K, Isobe K, Takai Y, Homma S.

Respirology · research support, non-u.s. gov't; journal article · DOI 10.1111/resp.12477

Bibliografisk träff 2015-02-01

Pirfenidone: a review of its use in idiopathic pulmonary fibrosis.

Kim ES, Keating GM.

Drugs · review; journal article · DOI 10.1007/s40265-015-0350-9

Bibliografisk träff 2015-01-03

Determination and pharmacokinetic study of pirfenidone in rat plasma by UPLC-MS/MS.

Sun W, Jiang ZL, Zhou L, Chen RM, Wang Z, Li WS, Jiang SM, Hu GX, Chen RJ.

J Chromatogr B Analyt Technol Biomed Life Sci · journal article · DOI 10.1016/j.jchromb.2014.12.027

Bibliografisk träff 2015-01-01

Pirfenidone treatment in idiopathic pulmonary fibrosis: A Saudi experience.

Alhamad EH.

Ann Thorac Med · research-article; journal article · DOI 10.4103/1817-1737.146866

Bibliografisk träff 2015-01-01

Improved pulmonary function following pirfenidone treatment in a patient with progressive interstitial lung disease associated with systemic sclerosis.

Udwadia ZF, Mullerpattan JB, Balakrishnan C, Richeldi L.

Lung India · journal article; case-report · DOI 10.4103/0970-2113.148451

Bibliografisk träff 2014-11-28

Assessment of 8-methosypsoralen, lomefloxacin, sparfloxacin, and Pirfenidone phototoxicity in Long-Evans rats.

Adachi T, Satou Y, Satou H, Shibata H, Miwa S, Iwase Y, Yamamoto T, Nishida A, Masutomi N.

Int J Toxicol · journal article · DOI 10.1177/1091581814559397

Bibliografisk träff 2014-11-07

Pirfenidone—a ray of hope in oral sub mucous fibrosis.

Shesha Prasad R, Pai A.

Oral Oncol · letter · DOI 10.1016/j.oraloncology.2014.10.011

Bibliografisk träff 2014-10-18

Efficacy of combined corticosteroid and pirfenidone for acute exacerbation of idiopathic pulmonary fibrosis after surgery for lung cancer: a case report.

Ohkubo H, Kunii E, Moriyama S, Niimi A.

Respir Investig · journal article; case reports · DOI 10.1016/j.resinv.2014.09.003